NCLEX Practice Test

Which medication reported by the client requires further investigation during medication reconciliation?

1. 0.3 mg of nitroglycerin sublingual PRN

2. 10 mg of ezetimibe PO once daily

3. 20 mg of lisinopril PO once daily

4. 200 mg of celecoxib PO once daily

The correct answer is: 0.3 mg of nitroglycerin sublingual PRN

The correct choice highlights a medication that might indicate a potential area of concern requiring further investigation. Nitroglycerin is commonly used for the management of angina and can have important implications for the client's cardiovascular status. The presence of nitroglycerin on the client’s medication list could suggest the need to monitor for cardiovascular issues, such as unstable angina or a history of myocardial infarction, indicating a higher risk for complications. During medication reconciliation, it is essential to investigate the reasons behind its use, including its efficacy, the frequency of use, and any recent changes in the client’s condition that might explain the need for this medication. Additionally, the administration method, sublingual, could also warrant questions about the client’s understanding of proper use and potential side effects such as hypotension. Consequently, ensuring that the client's use of nitroglycerin is appropriate and effectively managed is crucial in providing safe and individualized care. This thorough evaluation can help prevent possible adverse events related to this medication.